Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (4) , 633.e1-633.e7
Abstract
No abstract availableKeywords
Funding Information
- APSS
This publication has 12 references indexed in Scilit:
- Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infectionClinical Microbiology and Infection, 2020
- Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort studyeClinicalMedicine, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet, 2020
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)Journal of Clinical Virology, 2020
- Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoJournal of Clinical Microbiology, 2020
- Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, ChinaJournal of Medical Virology, 2020
- Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ChinaNature Medicine, 2020
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016